Enesi Pharma’s ImplaVax® Technology Platform Spotlighted in Medical Device Developments Article on Elimination of Cold Chain Logistics

OXFORD, UK – 22 June 2021 – Enesi Pharma is pleased to acknowledge Lynette Eyb’s excellent article ‘A Total Meltdown’ in Medical Device Developments’  where the potential of Enesi’s proprietary ImplaVax® formulation and delivery technologies are discussed.

The Article ‘A Total Meltdown‘ highlights how next generation vaccination technologies such as ImplaVax® needle-free, thermally stable unit solid dose vaccination platform could make a material impact on the ease of future deployment and reduce or eliminate the burden of cold chain logistics.